Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial)
Jan H. Cornel, Pierluigi Tricoci, Yuliya Lokhnygina, David J. Moliterno, Lars Wallentin, Paul W. Armstrong, Philip E. Aylward, Robert M. Clare, Edmond Chen, Sergio Leonardi, Frans Van De Werf, Harvey D. White, Claes Held, John Strony, Kenneth W. Mahaffey, Robert A. Harrington
Research output: Contribution to journal › Article › peer-review
15Scopus
citations
Fingerprint
Dive into the research topics of 'Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial)'. Together they form a unique fingerprint.